Skip to main content
. 2019 Jun 3;8(6):787. doi: 10.3390/jcm8060787

Figure 1.

Figure 1

Recurrence-free survival of (a) all patients included in the study and (b) comparison between patients with macrovascular invasion (MVA) alone (1), hepatic dissemination alone (2), and both macrovascular invasion and intrahepatic dissemination (3). Numbers of patients at risk are presented below the graphs.